Anne-Laure Joly
Karolinska Institutet · 25 works · 1,249 citations · h-index 14
Top works
- Dual Role of Heat Shock Proteins as Regulators of Apoptosis and Innate Immunity
- Anti-Cancer Therapeutic Approaches Based on Intracellular and Extracellular Heat Shock Proteins
- IL-1β promotes Th17 differentiation by inducing alternative splicing of FOXP3
- RETRACTED: Extracellular HSP27 mediates angiogenesis through Toll‐like receptor 3
- Heat shock protein 27 is involved in SUMO-2/3 modification of heat shock factor 1 and thereby modulates the transcription factor activity
- Heat Shock Proteins as Danger Signals for Cancer Detection
- Alternative Splicing of FOXP3 Controls Regulatory T Cell Effector Functions and Is Associated With Human Atherosclerotic Plaque Stability
- T cell responses at diagnosis of amyotrophic lateral sclerosis predict disease progression
- Foxp3 lacking exons 2 and 7 is unable to confer suppressive ability to regulatory T cells in vivo
- Microglia Induce PDGFRB Expression in Glioma Cells to Enhance Their Migratory Capacity
- The FOXP3Δ2 isoform supports Treg cell development and protects against severe IPEX syndrome
- MNK2 governs the macrophage antiinflammatory phenotype
- Serum Gp96 is a chaperone of complement-C3 during graft-versus-host disease
- Alternative splicing, FOXP3 and cardiovascular disease
- Immunological Profiling of Haemodialysis Patients and Young Healthy Individuals with Implications for Clinical Regulatory T Cell Sorting
- The FOXP3 full-length isoform controls the lineage-stability of CD4+FOXP3+ regulatory T cells
- Multi-faceted inhibition of dendritic cell function by CD4+Foxp3+ regulatory T cells
- Exploring the effect of various BoNT serotypes in a model of autonomic nervous system hyperactivity from rodents and humans: Paving the way to better targeting therapeutics in autonomic disorders?
- 437 Personalized tumor-trained lymphocytes – a neoantigen targeted T cell therapy product for treatment of colorectal cancer
- 643 A first in human phase I/IIa trial of personalized tumor-trained lymphocytes, pTTL, derived from regional lymph nodes for treatment of colorectal cancer